121 related articles for article (PubMed ID: 7599696)
1. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma.
Hiramatsu S; Sako Y; Mimura K; Ono Y; Iwashige K; Taniguchi S; Umeda F; Nawata H
Endocr J; 1995 Feb; 42(1):39-42. PubMed ID: 7599696
[TBL] [Abstract][Full Text] [Related]
2. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
[TBL] [Abstract][Full Text] [Related]
3. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
[TBL] [Abstract][Full Text] [Related]
4. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L
Diabetes; 1995 Jul; 44(7):837-44. PubMed ID: 7789652
[TBL] [Abstract][Full Text] [Related]
5. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU
Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758
[TBL] [Abstract][Full Text] [Related]
6. How reliable is the euglycaemic hyperinsulinemic clamp test for the confirmation of autonomous endogenous hyperinsulinemia?
Mićić D; Popović V; Sumarac M; Kendereski A; Nesović M; Djordjević P; Manojlović D; Mićić J
Exp Clin Endocrinol; 1990 Apr; 95(2):242-50. PubMed ID: 2163878
[TBL] [Abstract][Full Text] [Related]
7. C-peptide suppression test for insulinoma.
Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
[TBL] [Abstract][Full Text] [Related]
8. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
[TBL] [Abstract][Full Text] [Related]
9. [Hypoglycemic and hyperinsulinemic clamp technic to determine the secretory behavior of insulinoma].
Hütter R; Irsigler K; Vesely M; Ogris E
Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1146-8. PubMed ID: 2839328
[TBL] [Abstract][Full Text] [Related]
10. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
12. Insulin responses to selective arterial calcium infusion under hyperinsulinemic euglycemic glucose clamps: case studies in adult nesidioblastosis and childhood insulinoma.
Nakagawa A; Ueno K; Ito M; Okamoto S; Uehara K; Ito H; Mishina S; Kinoshita E; Nojima T; Takahashi H; Ikawa H; Takashima S; Nishizawa M; Nakano S; Kigoshi T; Nakabayashi H; Uchida K
Endocr J; 2007 Feb; 54(1):27-33. PubMed ID: 17053293
[TBL] [Abstract][Full Text] [Related]
13. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
[TBL] [Abstract][Full Text] [Related]
14. Lack of C-peptide suppression by exogenous hyperinsulinemia in subjects with symptoms suggesting reactive hypoglycemia.
Wasada T; Katsumori K; Saeki A; Kuroki H; Arii H; Saito S; Omori Y
Endocr J; 1996 Dec; 43(6):639-44. PubMed ID: 9075603
[TBL] [Abstract][Full Text] [Related]
15. Lack of insulin feedback inhibition in non-obese and obese men.
Peiris AN; Stagner JI; Vogel RL; Samols E; Nakagawa A
Metabolism; 1993 Mar; 42(3):371-5. PubMed ID: 8487657
[TBL] [Abstract][Full Text] [Related]
16. Feedback inhibition of insulin secretion is altered in cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Goria M; Pagano G; Lenti G
J Clin Endocrinol Metab; 1986 Oct; 63(4):1023-7. PubMed ID: 3528209
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia in the physiologic range is not superior to short-term fasting in suppressing insulin secretion in obese men.
Pincelli AI; Brunani A; Caumo A; Scacchi M; Pasqualinotto L; Tibaldi A; Dubini A; Bonadonna S; Cavagnini F
Metabolism; 2001 Jan; 50(1):107-11. PubMed ID: 11172483
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
[TBL] [Abstract][Full Text] [Related]
19. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
Nauck M; Stöckmann F; Creutzfeldt W
Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
